This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody & ADC Summit At ChinaBio
Shanghai, China
Kerry Hotel Pudong, Shanghai, ChinaApril 28–29, 2026

Dr. Shan Jiang, PhD
Chief Technology Officer at Hansoh Pharma
Speaker

Profile

Dr. Jiang Shan (江山), is the chief technology officer of the Group. She is in charge of the Group’s biopharmaceutical development and production operations.

Dr. Jiang has over 25 years of rich experience in the fields of biopharmaceuticals and ADC development. Prior to joining our Group, Dr. Jiang served as vice president of Pfizer from December 2023 to May 2024, responsible for the management of the Pharmaceutical Science Biotherapeutics department. From July 2008 to December 2023, she held positions ranging from director to vice president at Seagen, and was fully responsible for the development of large molecule pipelines. Dr. Jiang previously held R&D management positions at Bayer and BMS.

Agenda Sessions

  • Advancing ADCs to the Clinic: Case Study of Innovations in ADC Technology and Development

    10:40